Intas Pharmaceuticals Ltd.
Records under this name other than the patents Intas Pharmaceuticals Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.
Showing 1 to 5 of 5 · Back to Intas Pharmaceuticals Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,487,496 | Process for the preparation of cabazitaxel and its intermediates Lapsed on the fee record Ended Nov 8, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 8, 2024 | From the USPTO record |
| US 10,688,187 | Liquid pharmaceutical composition of adalimumab Lapsed on the fee record Ended Jun 23, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 23, 2024 | From the USPTO record |
| US 8,058,076 | In-vitro method for testing bioequivalence of iron-sucrose formulation Lapsed on the fee record Ended Nov 15, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 15, 2023 | From the USPTO record |
| US 6,710,195 | Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions Term ended Term ended Nov 26, 2022 · From the USPTO record | Term ended | Term ended Nov 26, 2022 | From the USPTO record |
| US 10,016,447 | Pharmaceutical composition having improved content uniformity Lapsed on the fee record Ended Jul 10, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 10, 2022 | From the USPTO record |